A phase I clinical trial to evaluate the safety of HU-045 for treating moderate-to-severe glabellar lines: a pilot study.
Hye Sung HanJ W ParkKwang Ho YooB J KimPublished in: Journal of the European Academy of Dermatology and Venereology : JEADV (2021)